Towards Personalization in the Curative Treatment of Gastric Cancer
Gastric cancer is the fifth most common cancer worldwide and has a high mortality rate.In the last decades, treatment strategy has shifted from an exclusive surgical approach to a multidisciplinary strategy.Treatment options for patients with resectable DHEA gastric cancer as recommended by different worldwide guidelines, include perioperative chem